Livongo Health, Inc. Common Stock
LVGO
LVGO was delisted on the 29th of October, 2020.
109 hedge funds and large institutions have $826M invested in Livongo Health, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 21 closing their positions.
172% more capital invested
Capital invested by funds: $304M → $826M (+$522M)
100% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 21
80% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 20
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
24% more funds holding
Funds holding: 88 → 109 (+21)
28% less call options, than puts
Call options by funds: $5.21M | Put options by funds: $7.19M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Southpoint Capital Advisors
New York
|
+$28.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$22.9M |
| 3 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$18.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.3M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$14.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
D1 Capital Partners
New York
|
-$13.6M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$8.73M |
| 3 |
NCL
Nishkama Capital LLC
Dorado,
Puerto Rico
|
-$8.05M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.66M |
| 5 |
Millennium Management
New York
|
-$6.45M |
LVGO Hedge Fund Activity: Q4 2019 in Review
109 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Livongo Health, Inc. Common Stock (LVGO) for Q4 2019, worth a combined $826M — up 172% from $304M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new LVGO positions and 21 closed out — a net gain of 21 holders — while 36 added to existing stakes and 20 trimmed.
The largest buyer was Southpoint Capital Advisors, opening a new position worth an estimated $28.7M. The largest seller was D1 Capital Partners, exiting entirely with an estimated $13.6M sold.
- 109 institutional investors held Livongo Health, Inc. Common Stock (LVGO) as of Q4 2019, up from 88 in Q3 2019.
- Funds reported $826M of Livongo Health, Inc. Common Stock stock for Q4 2019, up 172% quarter-over-quarter.
- 42 funds opened new Livongo Health, Inc. Common Stock positions in Q4 2019 and 21 closed out, a net change of +21 holders.
- The largest Livongo Health, Inc. Common Stock buyer in Q4 2019 was Southpoint Capital Advisors, an estimated $28.7M added.
- The largest Livongo Health, Inc. Common Stock seller in Q4 2019 was D1 Capital Partners, an estimated $13.6M sold.
Based on aggregated 13F filings for Q4 2019.